НовостиBenzingaRaymond James Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $42 Raymond James Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $42 Benzinga 2026.10.09 11:01 (GMT+0) Открыть на Benzinga Другие новости